Rare Disease Impact on Understanding Common Diseases
Cat Lutz, PhD, MBA, VP at JAX Rare Disease Translational Center, discusses rare disease research’s impact on understanding common diseases.
Cat Lutz, PhD, MBA, VP at JAX Rare Disease Translational Center, discusses rare disease research’s impact on understanding common diseases.
We have noticed an unusual activity from your IP 199.16.157.183 and blocked access to this
WASHINGTON, D.C., May 16, 2024, Today, the House of Representatives’ Energy and Commerce Health Subcommittee voted to advance several bipartisan bills
A local man is thankful for the groundbreaking research happening in a lab at the Stowers Institute in Kansas City, Missouri.
Learn more about the research grants of HCU Network America by getting in touch with our professional team today.
NIH-led findings point to a biomarker for rare disorders associated with the gene PNPLA6.
Molecular MRD after induction chemotherapy identifies patients with NPM1 AML who benefit from allogeneic transplant in first remission.Patients achieving M
A new medication is offering some ALS patients more hope than ever. It’s actually slowing the disease down in some people like Jessica Morris.
Fundraise smarter not harder. Raise more money effortlessly. With just a few clicks, you can get started quickly. Products can be purchased online and sent…
The Global Paroxysmal Nocturnal Hemoglobinuria (PNH) Patient Registry registry powered by NORD platform.
Aliya Khan, MD, at McMaster University, highlights the best practices to diagnose and treat tumor-induced osteomalacia (TIO)